Surrozen (SRZN) Research & Development (2020 - 2026)

Surrozen (SRZN) recorded quarterly Research & Development of $9.3 million in Q1 2026, up 3.75% quarter-over-quarter from $9.0 million in Q4 2025, and up 42.24% on a YoY basis from $6.6 million in Q1 2025.

Surrozen (SRZN) Research & Development (2020 - 2026) Analysis & Trends

Surrozen's Research & Development history runs 7 years deep, the most recent figure standing at $9.3 million for Q1 2026.

  • In Q1 2026, Research & Development rose 42.24% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $32.1 million (up 43.18% YoY), while the FY2025 annual figure was $29.4 million, up 38.96% from the prior year.
  • Research & Development was $9.3 million for Q1 2026 at Surrozen, up from $9.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $9.6 million in Q2 2022 to a low of $5.2 million in Q3 2024.
  • Historically, Research & Development has averaged $7.3 million across 5 years, with a median of $6.9 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Research & Development plunged 82.75% in 2022, then surged 68.06% in 2025.
  • A 5-year view of Research & Development shows it stood at $9.4 million in 2022, then slumped by 35.41% to $6.1 million in 2023, then decreased by 12.22% to $5.4 million in 2024, then soared by 68.06% to $9.0 million in 2025, then rose by 3.75% to $9.3 million in 2026.
  • The last three Research & Development figures came in at $9.3 million (Q1 2026), $9.0 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 4.32 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 15.66 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 626,092.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -101.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 1.46 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -2.30 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 357,444.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 961.60 Mn
9 Abivax 94.37 Bn 94.37 Bn - -58.00 Mn
10 Surrozen 225,877.86 -106.68 Mn - 9.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.33 Mn
Dec 31, 2025 8.99 Mn
Sep 30, 2025 7.77 Mn
Jun 30, 2025 6.04 Mn
Mar 31, 2025 6.56 Mn
Dec 31, 2024 5.35 Mn
Sep 30, 2024 5.20 Mn
Jun 30, 2024 5.34 Mn
Mar 31, 2024 5.25 Mn
Dec 31, 2023 6.10 Mn
Sep 30, 2023 6.11 Mn
Jun 30, 2023 6.94 Mn
Mar 31, 2023 8.09 Mn
Dec 31, 2022 9.44 Mn
Sep 30, 2022 8.62 Mn
Jun 30, 2022 9.58 Mn
Mar 31, 2022 9.37 Mn
Dec 31, 2021 10.89 Mn
Sep 30, 2021 50.00 Mn
Jun 30, 2021 10.27 Mn